Replies to post #243272 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

I believe CEO understands the urgency. IMO if he didn't understand the competitive landscape he would be taking on less risk by waiting for one FDA approval to fund the next NDA/ANDA's trials, and repeat the process. However, in going this route there are more risks and more hiccups as we've already seen. 2017 can be exciting year for the company, but depending on FDA responses, it may just be another year of delays. Hoping that isn't the case, but you can't ignore the fact it's what we've experienced so far. I'd like this to be the watershed moment for Elite, the year our tech is validated.

[John_Langston]

Investors see an opportunity in the mj field, most don't see an opportunity with ELTP.